期刊
CELL CYCLE
卷 15, 期 17, 页码 2256-2262出版社
TAYLOR & FRANCIS INC
DOI: 10.1080/15384101.2016.1208872
关键词
breast; EZH2; prostate; Polycomb; prognosis; PRC2; solid tumors; tumor suppressor
类别
资金
- European Research Council (ERC-Stg, REPODDID)
- Association pour la Recherche contre le Cancer (ARC)
EZH2, the main catalytic component of the Polycomb Repressive Complex 2 (PRC2) is apparently upregulated in most solid tumors. Furthermore its expression generally associates with poor prognosis. It was proposed that this correlation reflects a causal event, EZH2 mediating the silencing of key tumor suppressor loci. In contrast, we recently showed that EZH2 is dispensable for solid tumor development and that its elevated expression reflects the abnormally high proliferation rate of cancer cells. Here, we investigate the functional association between EZH2 expression and silencing of key tumor suppressor loci and further illustrate the confounding effect of proliferation on EZH2s association to outcome.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据